| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| August 22nd, 2009 | 31 | Yes |
Popular Name: GSK690693 GSK690693
Find On: PubMed — Wikipedia — Google
CAS Numbers: 937174-76-0 , [937174-76-0]
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.86 | 4.73 | -55.02 | 5 | 10 | 1 | 142 | 426.501 | 5 | ↓ |
| Hi High (pH 8-9.5) | 9.94 | 23.06 | -7.51 | 1 | 3 | 0 | 47 | 633.014 | 17 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Target | Akt | Selleck Chemicals |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AAPK2-1-E | AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 50 | 0.33 | Binding ≤ 10μM |
| AKT1-2-E | RAC-alpha Serine/threonine-protein Kinase (cluster #2 Of 3), Eukaryotic | Eukaryotes | 2 | 0.39 | Binding ≤ 10μM |
| AKT2-2-E | Serine/threonine-protein Kinase AKT2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4 | 0.38 | Binding ≤ 10μM |
| AKT3-2-E | Serine/threonine-protein Kinase AKT3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 9 | 0.36 | Binding ≤ 10μM |
| DAPK3-1-E | Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 81 | 0.32 | Binding ≤ 10μM |
| GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 138 | 0.31 | Binding ≤ 10μM |
| KGP1-1-E | CGMP-dependent Protein Kinase 1 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 33 | 0.34 | Binding ≤ 10μM |
| KPCB-1-E | Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 19 | 0.35 | Binding ≤ 10μM |
| KPCD-1-E | Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 14 | 0.35 | Binding ≤ 10μM |
| KPCE-1-E | Protein Kinase C Epsilon (cluster #1 Of 5), Eukaryotic | Eukaryotes | 21 | 0.35 | Binding ≤ 10μM |
| KPCL-2-E | Protein Kinase C Eta (cluster #2 Of 4), Eukaryotic | Eukaryotes | 2 | 0.39 | Binding ≤ 10μM |
| KPCT-1-E | Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.39 | Binding ≤ 10μM |
| KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1260 | 0.27 | Binding ≤ 10μM |
| KS6A5-1-E | Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 7940 | 0.23 | Binding ≤ 10μM |
| PAK4-1-E | Serine/threonine-protein Kinase PAK 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.36 | Binding ≤ 10μM |
| PAK6-1-E | Serine/threonine-protein Kinase PAK6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.37 | Binding ≤ 10μM |
| PAK7-1-E | Serine/threonine-protein Kinase PAK7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 52 | 0.33 | Binding ≤ 10μM |
| PRKX-1-E | Serine/threonine-protein Kinase PRKX (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.37 | Binding ≤ 10μM |
| ROCK1-1-E | Rho-associated Protein Kinase 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 890 | 0.27 | Binding ≤ 10μM |
| Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other | Other | 21 | 0.35 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AAPK2_RAT | Q09137 | AMP-activated Protein Kinase, Alpha-2 Subunit, Rat | 50 | 0.33 | Binding ≤ 1μM |
| KGP1_HUMAN | Q13976 | CGMP-dependent Protein Kinase 1 Beta, Human | 33 | 0.34 | Binding ≤ 1μM |
| DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 81 | 0.32 | Binding ≤ 1μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 138 | 0.31 | Binding ≤ 1μM |
| KPCB_HUMAN | P05771 | Protein Kinase C Beta, Human | 19 | 0.35 | Binding ≤ 1μM |
| KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 14 | 0.35 | Binding ≤ 1μM |
| KPCE_HUMAN | Q02156 | Protein Kinase C Epsilon, Human | 21 | 0.35 | Binding ≤ 1μM |
| KPCL_HUMAN | P24723 | Protein Kinase C Eta, Human | 2 | 0.39 | Binding ≤ 1μM |
| KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 2 | 0.39 | Binding ≤ 1μM |
| ROCK1_HUMAN | Q13464 | Rho-associated Protein Kinase 1, Human | 890 | 0.27 | Binding ≤ 1μM |
| AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 1 | 0.41 | Binding ≤ 1μM |
| AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 13 | 0.36 | Binding ≤ 1μM |
| AKT3_HUMAN | Q9Y243 | Serine/threonine-protein Kinase AKT3, Human | 13 | 0.36 | Binding ≤ 1μM |
| PAK4_HUMAN | O96013 | Serine/threonine-protein Kinase PAK 4, Human | 10 | 0.36 | Binding ≤ 1μM |
| PAK6_HUMAN | Q9NQU5 | Serine/threonine-protein Kinase PAK6, Human | 6 | 0.37 | Binding ≤ 1μM |
| PAK7_HUMAN | Q9P286 | Serine/threonine-protein Kinase PAK7, Human | 52 | 0.33 | Binding ≤ 1μM |
| PRKX_HUMAN | P51817 | Serine/threonine-protein Kinase PRKX, Human | 5 | 0.37 | Binding ≤ 1μM |
| AAPK2_RAT | Q09137 | AMP-activated Protein Kinase, Alpha-2 Subunit, Rat | 50 | 0.33 | Binding ≤ 10μM |
| KGP1_HUMAN | Q13976 | CGMP-dependent Protein Kinase 1 Beta, Human | 33 | 0.34 | Binding ≤ 10μM |
| DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 81 | 0.32 | Binding ≤ 10μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 138 | 0.31 | Binding ≤ 10μM |
| KPCB_HUMAN | P05771 | Protein Kinase C Beta, Human | 19 | 0.35 | Binding ≤ 10μM |
| KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 14 | 0.35 | Binding ≤ 10μM |
| KPCE_HUMAN | Q02156 | Protein Kinase C Epsilon, Human | 21 | 0.35 | Binding ≤ 10μM |
| KPCL_HUMAN | P24723 | Protein Kinase C Eta, Human | 2 | 0.39 | Binding ≤ 10μM |
| KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 2 | 0.39 | Binding ≤ 10μM |
| ROCK1_HUMAN | Q13464 | Rho-associated Protein Kinase 1, Human | 890 | 0.27 | Binding ≤ 10μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 1260 | 0.27 | Binding ≤ 10μM |
| KS6A5_HUMAN | O75582 | Ribosomal Protein S6 Kinase Alpha 5, Human | 7940 | 0.23 | Binding ≤ 10μM |
| AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 1 | 0.41 | Binding ≤ 10μM |
| AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 13 | 0.36 | Binding ≤ 10μM |
| AKT3_HUMAN | Q9Y243 | Serine/threonine-protein Kinase AKT3, Human | 13 | 0.36 | Binding ≤ 10μM |
| PAK4_HUMAN | O96013 | Serine/threonine-protein Kinase PAK 4, Human | 10 | 0.36 | Binding ≤ 10μM |
| PAK6_HUMAN | Q9NQU5 | Serine/threonine-protein Kinase PAK6, Human | 6 | 0.37 | Binding ≤ 10μM |
| PAK7_HUMAN | Q9P286 | Serine/threonine-protein Kinase PAK7, Human | 52 | 0.33 | Binding ≤ 10μM |
| PRKX_HUMAN | P51817 | Serine/threonine-protein Kinase PRKX, Human | 5 | 0.37 | Binding ≤ 10μM |
| Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 20 | 0.35 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Activation of BAD and translocation to mitochondria | |
| Activation of NF-kappaB in B cells | |
| Activation of PKB | |
| Activation of Rac | |
| AKT phosphorylates targets in the cytosol | |
| AKT phosphorylates targets in the nucleus | |
| AKT-mediated inactivation of FOXO1A | |
| APC truncation mutants have impaired AXIN binding | |
| Apoptotic cleavage of cellular proteins | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| Butyrate Response Factor 1 (BRF1) destabilizes mRNA | |
| Ca2+ pathway | |
| Calmodulin induced events | |
| CD28 dependent PI3K/Akt signaling | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| CREB phosphorylation | |
| CREB phosphorylation through the activation of Ras | |
| CRMPs in Sema3A signaling | |
| CTLA4 inhibitory signaling | |
| DAG and IP3 signaling | |
| deactivation of the beta-catenin transactivating complex | |
| Degradation of beta-catenin by the destruction complex | |
| Depolymerisation of the Nuclear Lamina | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| Disinhibition of SNARE formation | |
| Downregulation of ERBB2:ERBB3 signaling | |
| Downstream TCR signaling | |
| Effects of PIP2 hydrolysis | |
| eNOS activation | |
| EPHA-mediated growth cone collapse | |
| EPHB-mediated forward signaling | |
| ERK/MAPK targets | |
| FCERI mediated NF-kB activation | |
| G alpha (12/13) signalling events | |
| G alpha (z) signalling events | |
| G beta:gamma signalling through PI3Kgamma | |
| Gastrin-CREB signalling pathway via PKC and MAPK | |
| GPVI-mediated activation cascade | |
| HuR stabilizes mRNA | |
| Inactivation, recovery and regulation of the phototransduction cascade | |
| Inhibition of TSC complex formation by PKB | |
| Integrin alphaIIb beta3 signaling | |
| Interferon gamma signaling | |
| KSRP destabilizes mRNA | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| NCAM signaling for neurite out-growth | |
| Negative regulation of the PI3K/AKT network | |
| Netrin-1 signaling | |
| PDE3B signalling | |
| PIP3 activates AKT signaling | |
| Recycling pathway of L1 | |
| Regulation of HSF1-mediated heat shock response | |
| Response to elevated platelet cytosolic Ca2+ | |
| Role of DCC in regulating apoptosis | |
| Role of phospholipids in phagocytosis | |
| RSK activation | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| Sema4D induced cell migration and growth-cone collapse | |
| Senescence-Associated Secretory Phenotype (SASP) | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |
| Trafficking of GluR2-containing AMPA receptors | |
| Translocation of GLUT4 to the plasma membrane | |
| truncations of AMER1 destabilize the destruction complex | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation | |
| VEGFR2 mediated vascular permeability | |
| WNT5A-dependent internalization of FZD4 |
No pre-computed analogs available. Try a structural similarity search.